Clinical Trial Update: Exploring the Utility of [18F]3F4AP for Demyelination Imaging [Phase 1]

View source ↗

Summary

Phase 1 study investigating the PET radiotracer [18F]3F4AP for imaging demyelination. The trial is currently recruiting and aims to assess its utility across de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Demyelinating Diseases
• Multiple Sclerosis
• Spinal Cord Injury
• Spinal Radiculopathy

Drugs mentioned

• [18F]3F4AP

Snippet

Sponsor: Yale University | Conditions: Demyelinating Disorders, MCI | Phase 1 | Status: RECRUITING